User Name Password

back to homepage

KleenAir Systems (KSI.L) - a trading statement – of sorts
KSI.L
Comment by Objective Capital , Feb 21, 2008
Questions? Contact our analyst

The trading update contained little in the way of news or surprises. In particular it included no financial performance indicators. It described its perception of general market conditions, the results of a successful share placing, a minority investment and the appointment of a Non-Exec Director.

Objective's view:

The delay in mandated NOx emission reduction for heavy goods vehicles until 2012 has been known for some time, and KSI’s decision to concentrate for the time being on the opportunities presented by the introduction of the London LEZ was covered extensively in our recent initiation note (published 15 January 2008).

The placing of 7,094,400 new shares at 15.75p per share has been successfully completed and raises £1,117,368 before expenses and will provide a welcome boost to working capital. The placing was conducted by Charles Street Securities (CSS).

KSI has agreed to invest £300,000 for a 3.85% stake in NoNox plc. KSI believes this to be a complementary business as it provides filters for stationary boilers and generators in Italy. KSI discloses that a reverse take-over of NoNox was considered but will not proceed, although the companies are still discussing co-operation in several areas. We note that NoNox is unquoted with no publicly available financial data. It is hard to assess the value represented by KSI’s small minority stake having just raised much needed working capital.

We note also that the Non-Exec Director, Robert Hayim, is an MD at CSS Capital Partners LLP, an affiliate of Charles Street Securities which, according to its website, records a £1.5m fund raise for NoNox as a “Transaction in Progress” dated January 2006.

SIGN UP NOW FOR OBJECTIVE'S STOCK RESEARCH - IT'S FREE!

Objective, Independent, Experienced.
Research you can trust!

Yes! Subscribe me for the latest stock research from Objective.
Email address
My Password
My information:
First Name
Family Name
Title:
Job title:
Job function:
Industry:
I am a:
 
To receive occasional printed reports complete your mailing address:
 
Company Name (if any)
Address
 
 
City
Postcode/Zip
Country

Please Read Objective's Terms of Use.


Balkan Resources (Private) - exploring the Perlati copper deposit in Albania
Oct 09, 2009 | Previous Reports

Scancell Holdings (SCLP.PLUS) - differentiated technology and a focused plan offer ingredients for success
Sep 08, 2009 | Previous Reports

Sofame Technologies (SDW.V) - ambitious, but high risk growth strategy
Aug 24, 2009 | Previous Reports

Soho Resources (SOH.V) - substantial upgrade to total resource
Aug 19, 2009 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

e-Therapeutics (ETX.L) - ‘success-predictive’ drug discovery may be the key to new treatment horizons
Nov 18, 2008 | Previous Reports

Great Western Minerals (GWG.V) - pressing ahead with mine-to-market strategy
Nov 07, 2008 | Previous Reports

LiDCO (LID.L) - half year results show early signs of being on track
Oct 30, 2008 | Previous Reports

OCCASIONAL PAPERS

Albania - revisting old frontiers
October, 2008

The rise of independent research (IR Magazine)
March, 2006

Presentation to 2005 AIM Conference
Sept 26, 2005

The Role of Sponsored Research
June 22, 2005

Objective's Corporate Brochure
July 01, 2004

Objective Capital's Contact Information
Partnership, sales and product inquiries: marketing@objectivecapital.co.uk
Media services and conference requests: PR@objectivecapital.co.uk
Subscription and customer service issues: service@objectivecapital.co.uk
Comments or opinions on our analysis: analysis@objectivecapital.co.uk

11-12 Tokenhouse Yard, London EC2R 7AS, United Kingdom
ph +44-(0)870-080 2965 fax +44-(0)870-116 0839

About Us | Contact Us
Latest Analysis | Register Free | Archives
 
Copyright 2004 Objective Capital. All rights reserved.
Terms of Use | Privacy Policy | Disclaimer